ArticleBlood cancer journal2025

Combined MEK and JAK inhibition reduces osteopontin plasma level and bone marrow fibrosis in a myelofibrosis mouse model.

Lara Tavernari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.